We are live on ! Find out more
SLSN

Solesence Inc

0.8200 USD
-0.0601
6.83%
At close Updated Sep 17, 1:14 PM EDT
1 day
-6.83%
5 days
4.45%
1 month
-12.34%
3 months
-35.94%
6 months
-14.88%
Year to date
-45.33%
1 year
-74.77%
5 years
-54.19%
10 years
-54.19%
 

About: Solesence Inc is a health-oriented, science-driven company, focused on various skin health, beauty and wellness markets. Its primary skin health products are fully developed prestige skin care formulations with mineral-based UV protection enabled by proprietary Active Pharmaceutical Ingredients, which are also marketed as APIs for sale to manufacturers of other types of skin health products, including sunscreens and daily care products. Additionally, it continues to sell products in legacy markets, including medical diagnostics, architectural coatings, industrial coating applications, abrasion-resistant additives, and plastics additives applications. The company operates as a single business segment.

Employees: 115

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 14.3%
Neutral 85.7%
Negative 0%
Neutral
Zacks Investment Research
22 days ago
SLSN's Earnings Break-Even in Q2, High Operating Costs Hurt
Solesence's Q2 results are pressured by higher operating expenses, but improving production efficiency and expectations for a stronger second half provide reasons for optimism.
SLSN's Earnings Break-Even in Q2, High Operating Costs Hurt
Neutral
Seeking Alpha
28 days ago
Solesence, Inc. (SLSN) Q2 2026 Earnings Call Transcript
Solesence, Inc. (SLSN) Q2 2026 Earnings Call Transcript
Solesence, Inc. (SLSN) Q2 2026 Earnings Call Transcript
Neutral
GlobeNewsWire
28 days ago
Solésence Reports Second Quarter 2026 Financial Results
Please call Alissa Nakamoto at 216-509-9062 to confirm the details of the release. Please ensure that the release has the same distributions as past PRs.
Solésence Reports Second Quarter 2026 Financial Results
Neutral
GlobeNewsWire
1 month ago
Solésence To Report Second Quarter 2026 Financial Results and Host a Conference Call on August 11
ROMEOVILLE, Ill., July 28, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the second quarter of 2026 before the market opens on Tuesday, August 11, 2026, and host a conference call and webcast on the same date.
Solésence To Report Second Quarter 2026 Financial Results and Host a Conference Call on August 11
Positive
Zacks Investment Research
2 months ago
SLSN Unveils Two Scalp Care Products Using Patented Technology
Solesence expands its scalp care portfolio with a barrier-repair serum and SPF 45+ dry shampoo powered by patented technologies for hydration, oil control and UV protection.
SLSN Unveils Two Scalp Care Products Using Patented Technology
Neutral
GlobeNewsWire
2 months ago
Solésence Brings Patent-Backed Skin Health Innovation to Hair and Scalp
New White Label Collection, Powered by WHSPR™ and Kleair™, Debuts with Revitalizing Scalp Serum and Scalp Screen Dry Shampoo SPF 45+ Sunscreen
Solésence Brings Patent-Backed Skin Health Innovation to Hair and Scalp
Neutral
GlobeNewsWire
3 months ago
Solésence Named Contract Manufacturing Partner of the Year in the 2026 Cosmetics Business Innovation Awards
Global Award Recognizes Excellence in Service, Reliability, and Innovation ROMEOVILLE, Ill., June 18, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc.
Solésence Named Contract Manufacturing Partner of the Year in the 2026 Cosmetics Business Innovation Awards
Neutral
GlobeNewsWire
4 months ago
Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Allē Awards, Marking Fourth Year of Recognition
SPF-Infused Concealer Featuring Kleair™, WHSPR™, and Chromalüm™ Recognized Across Anti-Aging, Color Cosmetics, and Compromised Skin
Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Allē Awards, Marking Fourth Year of Recognition
Neutral
Zacks Investment Research
4 months ago
SLSN Incurs Q1 Loss Due to Shipment Delays, High Operating Costs
Solesence incurs a Q1 loss per share as shipment delays pressure revenues, even as gross margin improves and the company reaffirms its 2026 profitability targets.
SLSN Incurs Q1 Loss Due to Shipment Delays, High Operating Costs
Neutral
GlobeNewsWire
4 months ago
Solésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety Coalition
The report, led by the United Kingdom's APPG for Beauty, Hair & Wellbeing, calls for a national strategy to combat UV exposure, including Government support to enable access to adequate protection, build public awareness and combat misinformation.
Solésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety Coalition
Price charts implemented using Lightweight Charts™